Enhanced cytotoxicity of γδ-cytokine induced killer cells against hematologic malignancies

被引：0
|
作者：
Bloom, N.
Eldror, S.
Caspi, S.
Teihuman, S.
Vernitsky, H.
Jacoby, E.
Bielorai, B.
Toren, A.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P076
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 50 条
  • [1] Cytokine-induced killer cells: new insights for therapy of hematologic malignancies
    Sevari, Faezeh Ghanbari
    Mehdizadeh, Amir
    Abbasi, Khadijeh
    Hejazian, Seyyed Sina
    Raisii, Mortaza
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [2] Enhancing cytotoxicity of cytokine-induced killer cells against leukaemia
    Rettinger, E.
    Kuci, S. Selim
    Kuci, Z.
    Anzaghe, M.
    Willasch, A.
    Kreyenberg, H.
    Koehl, U.
    Fulda, S.
    Klingebiel, T.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S300 - S300
  • [3] Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies
    Pittari, Gianfranco
    Filippini, Perla
    Gentilcore, Giusy
    Grivel, Jean-Charles
    Rutella, Sergio
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [4] Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
    Rettinger, E.
    Kuci, S.
    Kuci, Z.
    Weber, G.
    Willasch, A.
    Kreyenberg, H.
    Koehl, U.
    Von Laer, D.
    Fulda, S.
    Klingebiel, T.
    Bader, P.
    KLINISCHE PADIATRIE, 2011, 223 (01): : 52 - 52
  • [5] Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions
    Merker, Michael
    Salzmann-Manrique, Emilia
    Katzki, Verena
    Huenecke, Sabine
    Bremm, Melanie
    Bakhtiar, Shahrzad
    Willasch, Andre
    Jarisch, Andrea
    Soerensen, Jan
    Schulz, Ansgar
    Meisel, Roland
    Bug, Gesine
    Bonig, Halvard
    Klingebiel, Thomas
    Bader, Peter
    Rettinger, Eva
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1281 - 1292
  • [6] Blinatumomab: enlisting serial killer T-cells in the war against hematologic malignancies
    Rogala, Britny
    Freyer, Craig W.
    Ontiveros, Evelena P.
    Griffiths, Elizabeth A.
    Wang, Eunice S.
    Wetzler, Meir
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 895 - 908
  • [7] Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
    Laport, Ginna G.
    Sheehan, Kevin
    Baker, Jeanette
    Armstrong, Randall
    Wong, Ruby M.
    Lowsky, Robert
    Johnston, Laura J.
    Shizuru, Judith A.
    Miklos, David
    Arai, Sally
    Benjamin, Jonathan E.
    Weng, Wen-Kai
    Negrin, Robert S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) : 1679 - 1687
  • [8] Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells
    Pan, Yueh
    Chiu, Ya-Hsu
    Chiu, Shao-Chih
    Cho, Der-Yang
    Lee, Liang-Ming
    Wen, Yu-Ching
    Whang-Peng, Jacqueline
    Hsiao, Chi-Hao
    Shih, Ping-Hsiao
    ANTICANCER RESEARCH, 2020, 40 (07) : 3865 - 3872
  • [9] CMV-Specific Cytokine-Induced Killer Cells Comprise Concomitant Cytotoxicity Against Leukemia and Cytomegalovirus
    Pfirrmann, Verena
    Oelsner, Sarah
    Rettinger, Eva
    Huenecke, Sabine
    Cinatl, Jindrich
    Wels, Winfried
    Klingebiel, Thomas
    Bader, Peter
    BLOOD, 2014, 124 (21)
  • [10] CYTOTOXICITY OF CYTOKINE-INDUCED KILLER-CELLS COATED WITH BISPECIFIC ANTIBODY AGAINST ACUTE MYELOID-LEUKEMIA CELLS
    KANEKO, T
    FUSAUCH, Y
    KAKUI, Y
    OKUMURA, K
    MIZOGUCHI, H
    OSHIMI, K
    LEUKEMIA & LYMPHOMA, 1994, 14 (3-4) : 219 - 229
12345